The full-year 2015 BioMeter paints the picture of a strong year for biotechnology, but deeper analysis shows a cautionary trend. The average BioMeter value for the entire year across all transactions reporting up-front...more
In This Issue:
- Castle Defense: Federal Circuit Reinforces Patent Damages Gate in VirnetX
- Standards Patent Licensing: Always Apportionment, Sometimes Stacking
- Supreme Court to Consider Good-Faith...more
1/6/2015
/ Biotechnology ,
Cisco ,
Expert Testimony ,
FRAND ,
Good Faith ,
IP License ,
Life Sciences ,
Patent Litigation ,
Patent Royalties ,
Patents ,
Royalties ,
SCOTUS